TELA
TELA Bio, Inc.
+0.04 (+3.39%)1.22USD189K成交股數54.8M市值–本益比(近四季)0.7股價營收比-4.5%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 19.3M-4% | 19.1M+3% | 20.9M+10% | 20.7M+29% | 20.2M+22% | 18.5M+9% | 19.0M+26% | 16.1M+11% | 16.6M | 17.0M | 15.1M | 14.5M |
| 營業成本 | 5.3M | 6.4M | 7.0M | 6.6M | 6.0M | 5.9M | 6.0M | 4.9M | 5.2M | 5.3M | 4.6M | 4.2M |
| 毛利 | 13.9M-1% | 12.5M+0% | 13.8M+7% | 14.0M+26% | 14.1M+24% | 12.5M+8% | 12.9M+24% | 11.1M+9% | 11.3M | 11.6M | 10.4M | 10.2M |
| 毛利率 | 72.3% | 65.7% | 65.9% | 67.5% | 69.8% | 67.6% | 67.8% | 68.8% | 68.3% | 68.4% | 69.0% | 70.4% |
| 研發費用 | 2.7M | 2.3M | 2.1M | 2.3M | 2.2M | 2.5M | 2.1M | 2.3M | 2.4M | 2.7M | 2.4M | 2.5M |
| 銷售管理費用 | 4.1M | 4.2M | 3.8M | 3.9M | 4.1M | 3.8M | 3.7M | 3.6M | 3.8M | 4.1M | 3.7M | 3.5M |
| 營業利益 | −9.3M+2% | −10.5M+1% | −6.6M-29% | −7.6M-35% | −9.1M+88% | −10.5M-15% | −9.4M-8% | −11.6M+12% | −4.8M | −12.3M | −10.2M | −10.4M |
| 營業利益率 | -48.1% | -55.2% | -31.9% | -36.5% | -45.0% | -56.5% | -49.4% | -71.9% | -29.1% | -72.2% | -67.6% | -71.5% |
| 稅後淨利 | −11.3M+13% | −12.3M+9% | −9.0M-13% | −8.6M-32% | −9.9M+75% | −11.3M-13% | −10.4M-5% | −12.6M+17% | −5.7M | −12.9M | −11.0M | −10.8M |
| 淨利率 | -58.4% | -64.4% | -43.2% | -41.6% | -49.1% | -60.8% | -54.7% | -78.3% | -34.1% | -76.0% | -72.8% | -74.4% |
| 稀釋 EPS | -0.20-9% | -0.21-16% | -0.17-60% | -0.19-63% | -0.22-4% | -0.25-50% | -0.42-7% | -0.51+11% | -0.23 | -0.50 | -0.45 | -0.46 |
| 稀釋股數 | 57.4M | 57.3M | 46.9M | 45.4M | 45.4M | 45.3M | 24.7M | 24.7M | 24.6M | 22.9M | 24.5M | 23.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 30.4M | 39.5M | 50.8M | 29.7M | 35.0M | 42.8M | 17.3M | 26.5M | 37.1M | 46.7M | 58.2M | 65.3M |
| 應收帳款 | 9.6M | 9.7M | 10.3M | 11.3M | 11.2M | 10.6M | 11.2M | 9.1M | 10.0M | 9.7M | 8.1M | 7.9M |
| 存貨 | 11.1M | 12.2M | 11.0M | 11.6M | 11.4M | 13.5M | 13.6M | 13.4M | 13.6M | 13.2M | 14.3M | 14.1M |
| 總資產 | 59.7M | 69.9M | 81.4M | 61.6M | 67.5M | 77.3M | 53.0M | 60.2M | 71.8M | 78.0M | 87.3M | 94.4M |
| 有息負債 | 56.1M | 55.9M | 55.7M | 41.5M | 38.1M | 41.3M | 41.0M | 40.8M | 40.7M | 40.5M | 40.4M | 40.2M |
| 總負債 | 75.6M | 75.1M | 75.1M | 60.0M | 58.4M | 59.1M | 59.3M | 57.3M | 57.5M | 59.2M | 56.8M | 54.4M |
| 股東權益 | −15.9M | −5.2M | 6.3M | 1.6M | 9.2M | 18.1M | −6.3M | 2.9M | 14.4M | 18.9M | 30.6M | 40.0M |
| 負債比 | 126.6% | 107.4% | 92.2% | 97.5% | 86.4% | 76.5% | 111.8% | 95.2% | 80.0% | 75.8% | 65.0% | 57.6% |
| 淨現金(現金 − 有息負債) | −25.7M | −16.3M | −4.8M | −11.8M | −3.1M | 1.6M | −23.7M | −14.3M | −3.5M | 6.2M | 17.8M | 25.1M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −11.2M+15% | – | – | – | −9.7M | – | – | −14.4M | – | – | – |
| 資本支出 | – | 119K | – | – | – | 32K | – | – | 304K | – | – | – |
| 自由現金流 | – | −11.3M+16% | – | – | – | −9.8M | – | – | −14.7M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -59.2% | – | – | – | -52.7% | – | – | -88.5% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 80.3M
| Single Reportable | 80.3M | 100.0% | +15.8% |
|---|
地區2025 年度 · 12.1M
| 美國以外 | 12.1M | 100.0% | +17.5% |
|---|
主要客戶2025 年度 · 80.3M
| Ovitex | 51.2M | 63.8% | +11.5% |
|---|---|---|---|
| Ovitex Prs | 27.3M | 34.0% | +20.1% |
| Other Customers | 1.7M | 2.2% | +177.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 80.3M | +15.8% | −38.8M | -48.3% | -0.83 | −28.7M |
| FY2024 | 69.3M | +18.6% | −37.8M | -54.5% | -1.33 | −42.6M |
| FY2023 | 58.5M | +41.1% | −46.7M | -79.9% | -2.04 | −41.5M |
| FY2022 | 41.4M | +40.6% | −44.3M | -106.9% | -2.72 | −41.6M |
| FY2021 | 29.5M | +61.8% | −33.3M | -112.9% | -2.30 | −31.1M |
| FY2020 | 18.2M | +17.9% | −28.8M | -158.1% | -2.23 | −24.6M |
| FY2019 | 15.4M | +86.7% | −22.4M | -145.2% | -17.10 | −25.7M |
| FY2018 | 8.3M | – | −21.1M | -254.9% | -101.41 | −20.0M |